New metagenomic approach aims to improve detection of meningitis and encephalitis infections

Researchers in Birmingham have developed a new approach that could improve the detection of infections affecting the central nervous system, including meningitis and encephalitis, by combining metagenomic sequencing with computational methods designed to distinguish genuine pathogens from background signals.

The research, led by Dr Ghaniah Hassan-Smith of Aston Medical School and University Hospitals Birmingham, addresses the difficulty of identifying the causative organism in many suspected central nervous system infections. Conventional testing typically involves cerebrospinal fluid obtained through lumbar puncture, followed by microscopy, culture and targeted PCR tests based on the organisms clinicians suspect.

However, in some settings, including intensive care, the causative pathogen is not identified in more than half of patients with suspected central nervous system infection. This can occur when an unexpected organism is responsible, pathogen levels are low, or treatment has already begun.

The researchers explored metagenomic sequencing, which analyses genetic material in a sample rather than testing for individual organisms. This can potentially detect a broad range of bacteria, viruses and other microorganisms, including unexpected causes of infection.

| Sign up to the ACNR email newsletter here |

A key challenge is that sequencing can also detect microbial material originating from contamination, including skin organisms or laboratory reagents. The team therefore developed a series of bioinformatics filters to help distinguish potentially significant pathogen signals from this background noise.

The method was tested using cerebrospinal fluid samples from patients with central nervous system infections treated at University Hospitals Birmingham and compared with samples from people with non-infectious neurological conditions. The approach combines multiple sequencing signals rather than relying on a single finding.

The researchers emphasised that metagenomic sequencing is not intended to replace conventional microbiology. Instead, the work aims to support more standardised interpretation of sequencing results and help bring the technology closer to routine clinical use.

The study, published in BMC Infectious Diseases, was a collaboration involving Aston University, University Hospitals Birmingham and the University of Birmingham.

This news item has been summarised using AI and checked by humans before publication.


Sources

Aston University

BMC Infectious Diseases

| Sign up for our online community for neurology specialists |